TMRW
7.12.2021 15:50:06 CET | Business Wire | Press release
Tmrw, a new and scalable Learning Operating System (LearnOS) for global education with a mission to help bring a quality education to every child, was launched this month.
This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20211207005768/en/
Its interoperable All-In-One Integrated Platform is built to be accessible and affordable for Government funded schools operating in both the developed and developing world settings. In particular, it seeks to reach all students irrespective of their background or their ability to pay. It is designed to cater to the needs of every curriculum, context and mode of learning, whether brick and mortar, virtual or blended. Tmrw’s vision over time is to underpin learning, teaching, and the operational needs of K12 education, higher education and life-long learning.
Sunny Varkey, who also founded the Global Teacher Prize, has ensured that Tmrw has been teacher-led from the drawing board to its final roll-out. Uniquely, he has been able to draw upon the teaching talent within the GEMS schools network, which includes 20,000 inspired and qualified teachers, teaching support staff and school administrators from all nationalities, delivering seven different curricula in 16 countries.
The ongoing COVID-19 pandemic has emphasised the urgent need for an integrated technological solution for global education that can streamline end-to-end processes and utilise data to improve teaching and learning, while providing a seamless experience for all. Tmrw seeks to fill this void by providing an education eco-system that offers far more than a traditional, stand-alone learning or school management system. Working in collaboration with schools and teachers, our ambition is that Tmrw becomes an accepted LearnOS of global education – giving every learner an opportunity to participate in the future.
Tmrw’s EdTech platform includes a comprehensive suite of modules that can be introduced as a full ecosystem or as bolt-ons that are interoperable with technologies from other providers, offering schools the efficiency gains that integration can bring.
The platform includes modules to manage and oversee the curriculum, assessment, and track student progress. It has non-academic functionalities such as sports management, counselling and well-being. It allows schools to manage parent and student relations and includes custom-built health and child safety guarding features. It also includes back-office operations such as revenue management, HR, payroll, finance and procurement.
Tmrw is not just a technology company, but an education transformation company that offers comprehensive educational services such as:
- Tmrw Academy – focused on professional development including teacher training
- Education Command Center – serving policy makers with real-time decision-making capabilities at a national level
- Tech-In-A-Box – Comprehensive technology backbone covering the school eco system end to end.
- Tmrw Advisory Services for educational institutions on curriculum design, digital transformation, school improvement and nation-wide educational strategies.
Spun out from GEMS Education, Tmrw has been incorporated as the independent technology entity of GEMS and so will draw on the experience of the largest private K-12 education provider in the world, where its solutions have proven themselves to be scalable and effective with real students in a real classroom environment. GEMS Education, since it was founded 62 years ago, has provided a quality and values driven education throughout the world.
During the pandemic, GEMS Education moved seamlessly online from the start of the crisis because for the last decade it has built, tested, and constantly improved an education platform with real teachers and real students in real classrooms. This culture of improvement, driven both by analytics and constant engagement with the experience of teachers and partners, will be at the heart of Tmrw.
Today, GEMS is the only private-sector education operator with an all-inclusive platform for teachers, pupils, and parents. That experience is the foundation of Tmrw, which seeks to create an impact on a billion learners through technology, backed by a team that has touched millions of lives over decades.
Mr. Sunny Varkey, Chairman and Founder of Tmrw and GEMS Education, said:
“Quality education is the great equaliser. It bridges the gap between the rich and the poor and gives us the greatest opportunity to improve the state of our world.
“We have built this platform to be accessible and affordable for Government funded schools throughout the world to help improve learning outcomes wherever we can. We seek to reach all students irrespective of their background or their ability to pay. Ultimately, our vision is to give every child their birth-right of a great education and provide hope for a better future.
“We can only achieve this mission if we learn lessons from the frontline of education. For far too long edtech has side-lined the voice of the teacher. Not this time, as teachers will be the beating heart of Tmrw. They will be our designers, our content creators and our toughest critics.”
Tmrw CEO and GEMS Education Group Chief Disruption Officer, Mr Krishnan Gopi, said:
“Education is transforming at pace, moving away from the conventional patterns of teaching and learning that have dominated the sector. There is an undeniable, growing awareness among educators and families that education must evolve to meet tomorrow’s reality.
“Designed by educators for educators, Tmrw will help students learn better, teachers teach better, parents become more engaged, and schools become more efficient”.
Our platform is secure, scalable, multi-lingual and highly configurable to meet different needs of education systems across the globe. It utilizes exponential technologies such as AI / ML, AR /VR, Blockchain and IOT to revolutionise the teaching and learning experience.
*For more information about how Tmrw can empower schools to deliver enhanced teaching and learning outcomes please email: info@tmrw.group
View source version on businesswire.com: https://www.businesswire.com/news/home/20211207005768/en/
About Business Wire
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
New Auction Record Set as Falcon Sells for AED 1.5 Million at ADIHEX 202629.8.2026 23:54:00 CEST | Press release
Qarmousha Pure Ultra White falcon sells for AED 1.5 million at the Abu Dhabi International Hunting and Equestrian Exhibition 2026 (ADIHEX) falcon auction Under the patronage of His Highness Sheikh Hamdan bin Zayed Al Nahyan, Ruler’s Representative in Al Dhafra Region and Chairman of the Emirates Falconers’ Club, the fifth auction held as part of the 23rd edition of the Abu Dhabi International Hunting and Equestrian Exhibition (ADIHEX) 2026 attracted remarkable turnout, culminating in the sale of a Qarmousha Pure Ultra White falcon for AED 1.5 million (USD 408,000). The sale marks the highest price achieved at any auction during this year’s edition of the exhibition. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260829032621/en/ Qarmousha Pure Ultra White (Photo: AETOSWire) This forms part of the largest auction programme in the exhibition’s history, held under the theme “A Legacy of Pride,” organised by ADNEC Group, a Modon
Takeda Receives U.S. FDA Approval of MIMRYLO™ (rusfertide), Marking a Potential Shift in the Treatment Paradigm for Polycythemia Vera29.8.2026 00:40:00 CEST | Press release
MIMRYLO, a First-in-Class Medicine with a Unique Mechanism of Action, is Approved for the Treatment of Erythrocytosis in Adults with Polycythemia Vera (PV)MIMRYLO Has Been Shown to Maintain Hematocrit Control, the Primary Treatment Goal in PV, as Well as Reduce Phlebotomy Burden and Improve FatigueApproval Supported by Phase 3 VERIFY Results Showing 76.9% of Patients Achieved Clinical Response During Weeks 20-32 Takeda (TSE:4502/NYSE:TAK)announced U.S. Food and Drug Administration (FDA) approval of the New Drug Application (NDA)* for MIMRYLO™ (rusfertide) for the treatment of erythrocytosis in adults with polycythemia vera (PV), a blood cancer. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260824773270/en/ MIMRYLO Logo MIMRYLO is a first-in-class hepcidin mimetic designed to regulate iron distribution in the body and red blood cell overproduction to control hematocrit levels, which is the ratio of red blood cells to the tot
Rigaku and Tohoku University Establish a New Research Institute for X-Ray Metrology28.8.2026 16:00:00 CEST | Press release
Rigaku Corporation, a group company of Rigaku Holdings and a global solutions partner for X-ray analytical systems (Head Office: Akishima, Tokyo; President and CEO: Jun Kawakami; “Rigaku”), and Tohoku University (Sendai, Miyagi; President: Teiji Tominaga; “Tohoku University”) have established the Rigaku-Tohoku University Co-Creation Research Institute for X-ray Metrology: Beyond The Limits (the “Institute”) at Tohoku University on August 1, 2026. The Institute will advance X-ray metrology technology, develop new metrology methods, and foster the next generation of researchers through an initial three-year collaboration, with the possibility of extension based on its achievements. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260828688510/en/ Inside the Institute As semiconductors become smaller, more multilayered, and incorporate a wider range of materials, manufacturing processes are becoming increasingly complex. X-ray me
BLK: Portfolio Company of Enry’s Island S.p.A., Lists on Euronext Dublin28.8.2026 15:34:00 CEST | Press release
Enry’s Island S.p.A. (WBAG:EIOS), an international venture builder with headquarters in the Tremiti Islands and the Metaverse, announces that BLK Global PLC, one of the portfolio companies within its ecosystem, has successfully completed its admission to trading on Euronext Access Dublin. Trading in the company’s shares commenced on Friday, July 31, 2026, under ticker BLKX and ISIN GB00BPSKS130. BLK was one of the thousands of applications received by Enry’s Island which, following an assessment process based on the Enry’s Model, was selected for a one-year incubation and acceleration programme. The programme supported the company through its subsequent growth stages, ultimately leading to its current stock market listing. Alessandro Pacciana, Investor Relations Manager of Enry’s Island S.p.A., said: “BLK’s listing is the second stock market listing in two years among Enry’s Island’s portfolio companies, while Enry’s Island itself is the world’s first listed venture builder. We are pro
Zambon Announces European Commission Approval of Hopledo® for Adults with Parkinson's Disease and Moderate to Severe Motor Fluctuations28.8.2026 11:00:00 CEST | Press release
Hopledo® is a first-in-class, oral, modified-release formulation of levodopa/carbidopa (LD/CD) approved for the treatment of motor fluctuations of Parkinson’s disease Zambon expects to begin the phased introduction of Hopledo® across European markets starting October 2026 The approval is based on data from the Phase 3 RISE-PD trial where Hopledo® demonstrated a significant increase in Good ON time compared with immediate-release LD/CD with fewer daily doses and a comparable safety profile Zambon today announced that the European Commission (EC) has granted marketing authorization for Hopledo® (modified-release levodopa/carbidopa) for the treatment of adult patients with Parkinson’s disease and moderate to severe motor fluctuations who have not been sufficiently stabilized with oral levodopa/dopa decarboxylase (DDC) inhibitor-based treatment regimens. Zambon expects to begin the phased introduction of Hopledo® across European markets starting October 2026. The company is working closely
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom
